Filing Details
- Accession Number:
- 0001493152-24-033196
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-19 19:00:05
- Reporting Period:
- 2024-08-15
- Accepted Time:
- 2024-08-19 19:00:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1862150 | Cingulate Inc. | CING | Pharmaceutical Preparations (2834) | 863825535 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1883920 | Laurie Myers | 1901 W. 47Th Place Kansas City KS 66205 | Evp And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-08-15 | 202 | $4.17 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The number of shares reflect the 1-for-20 and the 1-for-12 reverse stock splits of the Issuer's issued and outstanding shares of common stock, which became effective on November 30, 2023 and August 9, 2024, respectively.